BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Historical Holders from Q2 2021 to Q1 2025

CUSIP: 09061GAK7
Type / Class: Debt / NOTE 1.250% 5/1
All holders as of December 31, 2024: Q4 2024
Principal, excl. options: 434M
Holdings value: $404M
% of all portfolios: 0.001%
Grand Portfolio weight change: +0%
Number of holders: 71
Number of buys: 24
Number of sells: -24
Average Value change %: +0%
Average buys %: +0%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Period	Principal	Value	Change	Price	Investors
2025 Q1	$7.06M	$6.76M	+$148K	$0.94	4
2024 Q4	$434M	$404M	+$16.7M	$0.93	71
2024 Q3	$411M	$392M	-$44.1M	$0.95	61
2024 Q2	$458M	$439M	-$26.4M	$0.96	58
2024 Q1	$484M	$480M	+$12M	$0.99	57
2023 Q4	$392M	$404M	+$14.8M	$1.03	56
2023 Q3	$377M	$375M	+$15.1M	$0.99	47
2023 Q2	$362M	$366M	+$30.2M	$1.01	47
2023 Q1	$333M	$347M	+$77.6M	$1.04	44
2022 Q4	$257M	$283M	+$42.3M	$1.08	44
2022 Q3	$209M	$177M	-$103M	$0.99	36
2022 Q2	$320M	$282M	-$9.9M	$0.99	34
2022 Q1	$323M	$295M	+$130M	$1.00	28
2021 Q4	$217M	$195M	-$31.4M	$1.04	32
2021 Q3	$249M	$436M	+$2.61M	$1.00	26
2021 Q2	$244M	$247M	+$247M	$1.00	28